ArticleSignal transduction and targeted therapy2025

Lysophosphatidylethanolamine 18:1 drives clear cell renal cell carcinoma by stabilizing SIRT6 to reprogram lipid metabolism.

Nanxi Yue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.